Development of CRISPR-Cas13a-based antimicrobials capable of sequence-specific killing of target bacteria.

Kiga K, Tan XE, Ibarra-Chavez R, Watanabe S, Aiba Y, Sato'o Y, Li FY, Sasahara T, Cui B, Kawauchi M, Boonsiri T, Thitiananpakorn K, Taki Y, Azam AH, Suzuki M, Penades JR, Cui L
Nat Commun. 2020 Jun 10;11(1):2934. doi: 10.1038/s41467-020-16731-6. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.